WO2026056930 - HETEROCYCLIC COMPOUND AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/056930
Publication Date
19.03.2026
International Application No.
PCT/CN2025/120468
International Filing Date
10.09.2025
Title **
[English]
HETEROCYCLIC COMPOUND AND USE THEREOF
[French]
COMPOSÉ HÉTÉROCYCLIQUE ET SON UTILISATION
[Chinese]
一种杂环化合物及其用途
Applicants **
CHENGDU MFS PHARMA.CO., LTD.
Inventors
CHEN, Guangwu
LIU, jin
ZHANG, wensheng
ZHANG, Hancheng
WANG, Changhua
Priority Data
202411287190.X
13.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2002 | |
| EPO | Filing, Examination, Granting | 13203 | |
| Japan | Filing, Examination, Granting | 1998 | |
| South Korea | Filing, Examination, Granting | 1804 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,747
Contact Us
Abstract[English]
Provided in the present invention are a heterocyclic compound and the use thereof, belonging to the technical field of pharmaceutical chemistry. A series of heterocyclic compounds prepared in the present invention have highly efficient sedative, hypnotic, and/or anesthetic effects, can control status epilepticus, and also have analgesic effects, thus providing a new option for the clinical preparation of a drug having analgesic effects, a drug having anesthetic, sedative, and hypnotic effects and/or capable of controlling status epilepticus, and a drug having anesthetic, sedative, and hypnotic effects and/or capable of controlling status epilepticus which also has analgesic effects.[French]
La présente invention concerne un composé hétérocyclique et son utilisation, appartenant au domaine technique de la chimie pharmaceutique. Une série de composés hétérocycliques préparés selon la présente invention ont des effets sédatifs, hypnotiques et/ou anesthésiques hautement efficaces, peuvent réguler l'état épileptique, et ont également des effets analgésiques, fournissant ainsi une nouvelle option pour la préparation clinique d'un médicament ayant des effets analgésiques, un médicament ayant des effets anesthésiques, sédatifs et hypnotiques et/ou capable de lutter contre l'état épileptique, et un médicament ayant des effets anesthésiques, sédatifs et hypnotiques et/ou capable de lutter contre l'état épileptique qui a également des effets analgésiques.[Chinese]
本发明提供了一种杂环化合物及其用途，属于药物化学技术领域。本发明制备的一系列杂环化合物，具有高效的镇静、催眠和/或麻醉作用，能够控制癫痫持续状态，同时还具有镇痛作用，为临床上制备具有镇痛作用的药物，具有麻醉、镇静、催眠作用和/或能够控制癫痫持续状态的药物，以及既具有麻醉、镇静、催眠作用和/或能够控制癫痫持续状，同时还具有镇痛作用的药物提供了一种新的选择。